NLS Pharmaceutics Ltd. (NCEL) at a glance

NLS Pharmaceutics Ltd. (NCEL) is a Healthcare company. It trades at $3.24. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Safety (60/100) and its weakest is Momentum (16/100).

Price
$3.24
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$1.83 to $30.80
Vestovix Score47/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
16